I think there won't be much work at all to get them ready

New Post Public Reply Private Reply Replies (2) Message Board
kilo RobInvest #2068

I think there won't be much work at all to get them ready for an audit. Also MVP and FIT can suck on those emails lol. If you look there has been no pocketing of cash by Matt, so the "ATM" statement being made on ISLUT is disproved. The fact that there is no TA is disproved. Also if you look at the legal proceedings, Matt is not part of or ever been convicted of a scam. We should see a PR tomorrow, just a "gut" feeling. Whether it is a "feel good" PR or not, I guess that depends on who is reading it! So far this is the list of BS that has been disproved by BARON

1. No BID is coming soon! (saying that for what three months now).

2. Matt is a criminal

3. Matt is using BCAP as his own personal ATM

4. A/S increase (not happening, still no filing)

5. There is no TA!

Now we need to work on interest for preferred shares. I have put my name in the hat last week for the minimum investment of $5,000. So far I believe we have around $70,000 from one investment group alone, this does not include what Matt has been able to get commitments on. Right now there is a small amount of shares at 2, they could be wiped out very easily. From glancing at the FINS ny personal opinion is that they look extremely good for a company who only operated for 8 month out of 12 last year. I am glad to see that Matt has been able to liquidate some of his holdings. I guess I stand corrected, I did not think he would be able to do so until the name change. On that note, I have seen some claiming that RIGH was chilled. A one for one status is far different from being chilled, this is done to try to stop naked shorts and manipulation. Matt will still be able to liquidate every month as he has planned.

   I am very happy with the FINS so far man, they are exactly what I expected to see ( a little better even).

KILO

Baron Capital Enterprise, INC. (BCAP) Stock Research Links

BCAP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Huawei Introduces Innovative Wearables for Enhanced Connectivity

Updated Category News Views 293

Huawei Unveils Next-Generation Wearables and Tablets At a much-anticipated event, Huawei Consumer Business Group (CBG) revealed a thrilling array of new products. This launch showcased a strong emphasis on trendy wearables and sophisticated tablets, highlighting the brand's dedication to innovation and a user-friendly design. Chic Wearables for Style and Utility Among the...

Continue Reading
Investigating Barnes & Noble Education: Shareholder Rights Explained

Updated Category News Views 155

Understanding the Investigation of Barnes & Noble Education In a proactive move for investors, the law firm Bragar Eagel & Squire, P.C. is currently investigating Barnes & Noble Education, Inc. (BNED). This investigation aims to determine whether the company potentially breached federal securities laws or engaged in unlawful business practices that could lead to...

Continue Reading
Bailey Kennedy Achieves Landmark Legal Win for Talisman Group

Updated Category News Views 171

Bailey Kennedy Achieves Legal Victory for Talisman Group Judge Rules LNW Violated Talisman's Distribution Agreement by Marketing Competing Game In a significant legal development, Bailey Kennedy, LLP has successfully represented The Talisman Group, LLC, the innovative minds behind EZ Baccarat. The firm has recently triumphed in a legal dispute against LNW Gaming, Inc.,...

Continue Reading
Join the Class Action Lawsuit Against Ardelyx, Inc. Now

Updated Category News Views 49

Join the Class Action Lawsuit Against Ardelyx, Inc. Attention Ardelyx, Inc. investors! There's an important class action lawsuit underway, and this is your opportunity to get involved. Bronstein, Gewirtz & Grossman, LLC, a respected law firm known for its dedication to investor advocacy, has announced a class action case involving Ardelyx, Inc. (NASDAQ: ARDX) and certain...

Continue Reading
Aileron Therapeutics Unveils Q3 2024 Financial Performance

Updated Category News Views 97

Aileron Therapeutics Reports Impressive Q3 2024 Financial Results Aileron Therapeutics, Inc. (NASDAQ: ALRN), a biopharmaceutical company committed to developing innovative medicines for orphan pulmonary diseases, has recently showcased significant progress with their third-quarter financial results. This quarter has been marked by promising advancements in clinical trials...

Continue Reading